These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10077879)

  • 1. Determination of phenytoin in sections of head hair: a preliminary study to evaluate the history of drug use.
    Tsatsakis AM; Psillakis T; Stefis A; Assithianakis P; Vlahonikolis IG; Michalodimitrakis MN; Helidonis E
    Boll Chim Farm; 1998 Dec; 137(11):459-66. PubMed ID: 10077879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin concentration in head hair sections: a method to evaluate the history of drug use.
    Tsatsakis AM; Psillakis T; Paritsis N
    J Clin Psychopharmacol; 2000 Oct; 20(5):560-73. PubMed ID: 11001242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine levels in head hair of patients under long-term treatment: a method to evaluate the history of drug use.
    Psillakis T; Tsatsakis AM; Christodoulou P; Michalodimitrakis M; Paritsis N; Helidonis E
    J Clin Pharmacol; 1999 Jan; 39(1):55-67. PubMed ID: 9987701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study.
    Tsatsakis AM; Psillakis TK; Tzatzarakis M; Kourtopoulos H; Paritsis N
    Clin Chim Acta; 1997 Jul; 263(2):187-95. PubMed ID: 9246423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative determination of phenytoin in plasma by fluorescence polarization immunoassay and high performance liquid chromatography.
    Othman S; al-Turk WA; Awidi AS; Daradkeh TK; Shaheen O
    Drug Des Deliv; 1987 Sep; 2(1):41-7. PubMed ID: 3334544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of phenytoin and carbamazepine in human hair by high-performance liquid chromatography.
    Mei Z; Williams J
    Ther Drug Monit; 1997 Feb; 19(1):92-4. PubMed ID: 9029755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of plasma levels of phenytoin. Evaluation of 2 techniques].
    Estruch J; Galdames D; Varas S; Saavedra I
    Rev Med Chil; 1989 Aug; 117(8):903-6. PubMed ID: 2519450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
    Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
    Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
    Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
    J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance monitoring in epileptic patients.
    Chandra RS; Dalvi SS; Karnad PD; Kshirsagar NA; Shah PU
    J Assoc Physicians India; 1993 Jul; 41(7):431-2. PubMed ID: 8300489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of three methods for predicting concentrations of free phenytoin.
    Beck DE; Farringer JA; Ravis WR; Robinson CA
    Clin Pharm; 1987 Nov; 6(11):888-94. PubMed ID: 3677566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
    Brauchli YB; Scholer A; Schwietert M; Krähenbühl S
    Clin Chim Acta; 2008 Mar; 389(1-2):174-6. PubMed ID: 18082631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.
    Pattanaik S; Hota D; Prabhakar S; Kharbanda P; Pandhi P
    Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity.
    Yilmaz Y; Tasdemir HA; Paksu MS
    Eur J Paediatr Neurol; 2009 Sep; 13(5):439-43. PubMed ID: 18922714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.